Avalo Therapeutics, Inc. (AVTX) SEC filings
AVTX SEC filings moved a median of -0.88% by the close. AVTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AVTX overview →
93 measured AVTX SEC filing events.
Where these AVTX SEC filings landedvs 93 measured AVTX SEC filing reactions
| Middle 50% of AVTX SEC filing reactions | -3.61% to +2.02% |
|---|---|
| Median reaction (to close) | -0.88% |
| Measured reactions | 93 |
Point-in-time · zero look-ahead
Half of the 93 AVTX SEC filing events with a measured close landed between -3.61% and +2.02%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Avalo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +4.39% | +4.64% | |
| Form 8-K Avalo Therapeutics, Inc. For: Aug 06 | SEC filing · Form 8-K | +4.39% | +4.64% | |
| Form EFFECT Avalo Therapeutics, Inc. | SEC filing · Form EFFECT | -0.56% | -3.40% | |
| Form S-3 Avalo Therapeutics, Inc. | SEC filing · Form S-3 | +0.26% | -6.38% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 23 | SEC filing · Form 8-K | +2.50% | +6.26% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 16 | SEC filing · Form 8-K | -1.10% | -1.78% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | +0.67% | -2.73% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 02 | SEC filing · Form 8-K | +0.54% | -0.23% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.86% | -1.78% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | -1.86% | -1.78% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 05 | SEC filing · Form 8-K | +1.44% | +2.56% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 05 | SEC filing · Form 8-K | -3.28% | -4.68% | |
| Form 8-K Avalo Therapeutics, Inc. For: Apr 26 | SEC filing · Form 8-K | +3.30% | -9.69% | |
| Form ARS Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.79% | -1.48% | |
| Form DEF 14A Avalo Therapeutics, Inc. For: Apr 10 | SEC filing · Form DEF | +1.79% | -1.48% | |
| Form DEFA14A Avalo Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.79% | -1.48% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 23 | SEC filing · Form 8-K | -0.69% | +1.46% | |
| Form 10-K Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.19% | +0.60% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 23 | SEC filing · Form 8-K | +1.19% | +0.60% | |
| Form S-8 Avalo Therapeutics, Inc. | SEC filing · Form S-8 | +1.19% | +0.60% | |
| Form EFFECT Avalo Therapeutics, Inc. | SEC filing · Form EFFECT | +2.06% | +6.49% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jan 12 | SEC filing · Form 8-K | -0.82% | -2.57% | |
| Form S-3 Avalo Therapeutics, Inc. | SEC filing · Form S-3 | +0.38% | -1.28% | |
| Form 8-K Avalo Therapeutics, Inc. For: Dec 02 | SEC filing · Form 8-K | -0.47% | -6.48% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.98% | -2.53% | |
| Form 8-K Avalo Therapeutics, Inc. For: Nov 06 | SEC filing · Form 8-K | +3.98% | -2.53% | |
| Form S-8 Avalo Therapeutics, Inc. | SEC filing · Form S-8 | +3.98% | -2.53% | |
| Form 8-K Avalo Therapeutics, Inc. For: Oct 29 | SEC filing · Form 8-K | -0.49% | -0.88% | |
| Form 8-K Avalo Therapeutics, Inc. For: Oct 10 | SEC filing · Form 8-K | +0.20% | -5.23% | |
| Form 8-K Avalo Therapeutics, Inc. For: Sep 29 | SEC filing · Form 8-K | +2.34% | +1.25% | |
| Form 8-K Avalo Therapeutics, Inc. For: Sep 16 | SEC filing · Form 8-K | +2.31% | +3.81% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Avalo Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 20 | SEC filing · Form 8-K | -1.04% | -3.53% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.00% | +5.54% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.00% | +5.54% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | +0.00% | -5.31% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 04 | SEC filing · Form 8-K | +2.86% | -1.58% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.21% | -3.61% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 12 | SEC filing · Form 8-K | +1.21% | -3.61% | |
| Form S-8 Avalo Therapeutics, Inc. | SEC filing · Form S-8 | +1.21% | -3.61% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 08 | SEC filing · Form 8-K | +0.00% | -2.25% | |
| Form ARS Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.40% | +0.60% | |
| Form DEF 14A Avalo Therapeutics, Inc. For: Jun 17 | SEC filing · Form DEF | +1.40% | +0.60% | |
| Form DEFA14A Avalo Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.40% | +0.60% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 25 | SEC filing · Form 8-K | -3.82% | -6.07% | |
| Form 10-K Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +3.01% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 20 | SEC filing · Form 8-K | — | +3.01% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jan 13 | SEC filing · Form 8-K | +0.00% | -2.42% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jan 01 | SEC filing · Form 8-K | +0.00% | +12.40% | |
| Form 8-K Avalo Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | +0.00% | +0.50% | |
| Form 8-K Avalo Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | -3.14% | -2.81% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +3.94% | |
| Form 8-K Avalo Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +0.00% | +3.94% | |
| Form S-8 Avalo Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | +3.94% | |
| Form 8-K Avalo Therapeutics, Inc. For: Oct 08 | SEC filing · Form 8-K | +0.00% | +1.16% | |
| Form 8-K Avalo Therapeutics, Inc. For: Sep 09 | SEC filing · Form 8-K | — | +6.67% | |
| Form 8-K Avalo Therapeutics, Inc. For: Sep 03 | SEC filing · Form 8-K | +0.00% | -6.23% | |
| Form 8-K Avalo Therapeutics, Inc. For: Aug 13 | SEC filing · Form 8-K | +4.11% | -0.64% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.68% | -7.48% | |
| Form 8-K Avalo Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | -1.68% | -7.48% | |
| Form EFFECT Avalo Therapeutics, Inc. | SEC filing · Form EFFECT | — | +4.33% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jul 29 | SEC filing · Form 8-K | +0.38% | +7.16% | |
| Form S-3/A Avalo Therapeutics, Inc. | SEC filing · Form S-3 | — | -7.71% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jul 15 | SEC filing · Form 8-K | — | +0.81% | |
| Form 10-Q/A Avalo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.80% | |
| Form S-3/A Avalo Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | -2.80% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jul 09 | SEC filing · Form 8-K | +0.00% | +2.02% | |
| Form ARS Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.30% | |
| Form DEF 14A Avalo Therapeutics, Inc. For: Aug 13 | SEC filing · Form DEF | +0.00% | +0.30% | |
| Form DEFA14A Avalo Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +0.30% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jun 24 | SEC filing · Form 8-K | +0.00% | +4.35% | |
| Form 8-K/A Avalo Therapeutics, Inc. For: Mar 27 | SEC filing · Form 8-K | +0.00% | +3.46% | |
| Form PRE 14A Avalo Therapeutics, Inc. For: Jun 07 | SEC filing · Form PRE | — | -4.31% | |
| Form S-3 Avalo Therapeutics, Inc. | SEC filing · Form S-3 | — | -4.31% | |
| Form 8-K/A Avalo Therapeutics, Inc. For: Mar 27 | SEC filing · Form 8-K | +0.00% | +0.26% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 20 | SEC filing · Form 8-K | +0.00% | +19.31% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.82% | +1.50% | |
| Form 8-K Avalo Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | +0.82% | +1.50% | |
| Form D Avalo Therapeutics, Inc. | SEC filing · Form D | +1.22% | +5.32% | |
| Form 10-K Avalo Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -6.95% | -10.50% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 29 | SEC filing · Form 8-K | -6.95% | -10.50% | |
| Form 8-K Avalo Therapeutics, Inc. For: Mar 27 | SEC filing · Form 8-K | +8.36% | +16.31% | |
| Form DEFA14A Avalo Therapeutics, Inc. | SEC filing · Form DEFA14A | +8.36% | +16.31% | |
| Form 8-K Avalo Therapeutics, Inc. For: Jan 30 | SEC filing · Form 8-K | +1.29% | -1.07% | |
| Form 8-K Avalo Therapeutics, Inc. For: Dec 28 | SEC filing · Form 8-K | -1.65% | -10.52% | |
| Form 8-K Avalo Therapeutics, Inc. For: Dec 20 | SEC filing · Form 8-K | -11.37% | -16.39% | |
| Form 8-K Avalo Therapeutics, Inc. For: Dec 07 | SEC filing · Form 8-K | -4.64% | -6.34% | |
| Form DEFA14A Avalo Therapeutics, Inc. | SEC filing · Form DEFA14A | -4.64% | -6.34% | |
| Form 8-K Avalo Therapeutics, Inc. For: Nov 14 | SEC filing · Form 8-K | -0.92% | -5.93% | |
| Form 10-Q Avalo Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.94% | -8.41% | |
| Form 8-K Avalo Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | +0.94% | -8.41% | |
| Form 8-K Avalo Therapeutics, Inc. For: Oct 27 | SEC filing · Form 8-K | +4.40% | +0.46% |
Keep exploring
More AVTX: earnings → · analyst actions → · AVTX overview →